symptoms
When a symptom needs a clinician
The short list this community keeps: the symptoms that mean seek urgent care today rather than asking a forum. Written to be read once now, before anything is wrong.
A peer support community, independent and not for sale. Since February 2024.
Uncommon, serious, and the reason this community has a low threshold for getting abdominal pain seen. The presentation, the evidence, and what to do.
8 min read1.1k wordsUpdated 19 June 2026Reviewed by Mira
This is a short guide about an uncommon problem, and the reason it exists is that the cost of not knowing is high and the cost of knowing is four minutes.
Acute pancreatitis is inflammation of the pancreas. Most cases in the general population are caused by gallstones or by alcohol. It is usually treated in hospital, most people recover, and a minority become seriously unwell. It is not something to manage at home under any circumstances, and it is not something anybody can distinguish from severe indigestion by feel — including the person having it, and including us.
Mira, who spent eleven years on a metabolic ward before she came to peer support, wrote this section and asked us to keep it blunt: if the pain in this guide is your pain, the correct action is to be assessed today. Nothing else in this guide matters as much as that sentence.
The classic presentation is specific enough to be worth memorising.
What it is not: the queasy, full, uncomfortable feeling that is the ordinary experience of these medicines. GLP-1 nausea is unpleasant. This is pain, and it does not stop.
If you are unsure — and people are unsure, because bodies are ambiguous — that uncertainty is the reason to get seen rather than the reason to wait. Nobody in a hospital is annoyed by an abdominal pain that turns out to be severe indigestion.
Practically, in order.
Assessment usually involves blood tests — amylase or lipase — and often a scan. Diagnosis is not made on symptoms alone, which is the whole reason home guesswork fails.
Here is where honesty is more useful than reassurance or alarm.
The large trials in this class have not demonstrated a clear excess of pancreatitis. In STEP 1 (Wilding, NEJM, 2021) cases were very few. SUSTAIN 6 (Marso, NEJM, 2016), SELECT (Lincoff, NEJM, 2023) and FLOW (Perkovic, NEJM, 2024) collectively followed large numbers of people for years without pancreatitis emerging as a headline safety signal, and the same is true across the tirzepatide programme.
At the same time, the product labels for this class carry a warning about pancreatitis, based on post-marketing reports and on the biology of a drug class acting on the pancreas. Cases have occurred in people taking these medicines. Whether at a higher rate than in a comparable population not taking them is genuinely unsettled.
Mira’s framing, which we think is the right one: this is a rare event that the trials were not sized to detect and that would be serious if it happened to you. Rare and serious is precisely the combination that justifies a low threshold for assessment and does not justify fear.
There is one clear connection worth knowing: gallstones cause pancreatitis, and gallstones are somewhat more common on these medicines and during rapid weight loss generally. The gallbladder guide covers that link.
Things worth raising with a prescriber before starting, or at your next appointment if you have already started.
Members who have been through an episode ask the same question in side-effect-support: can I go back on it.
That is entirely a clinical decision, it depends on the cause and severity, and different clinicians in different countries have come to different conclusions for different members. What we can tell you is that the conversation exists and is worth having properly rather than assuming the answer is no or assuming it is yes.
Two members have written about their episodes in the journals, and both said the same thing about the days beforehand: the pain was different from anything the medicine had done before, and they spent hours arguing with themselves about whether it was worth bothering anybody. If that is where you are as you read this, please stop arguing and go. It is what the argument is for.
And if it turns out to be nothing serious, you will have had an uncomfortable evening and a definite answer, and you will be the person in circle next month telling somebody else to go and get seen. That is how this community actually works.
symptoms
The short list this community keeps: the symptoms that mean seek urgent care today rather than asking a forum. Written to be read once now, before anything is wrong.
symptoms
Gallstones turn up more often on these medicines than on placebo, and rapid weight loss causes them anyway. What the evidence supports, and the pain pattern to know.
symptoms
Why nausea happens on these medicines, how common it really was in the trials, what several hundred members have found helps, and where it stops being ordinary.
eating
Many members find drinking changes on these medicines — less desire, worse effects, or both. What is actually known, and the safety points that are not negotiable.
clinicalhow-to
How to open a set of results without your stomach dropping — what a reference range actually means, which numbers move for dull reasons, and when to ring somebody today.
clinicalhow-to
How to get something useful out of ten minutes — the one-page prep, the opening sentence that changes the appointment, and what to ask for in writing before you leave.